The American Association for Cancer Research (AACR) was formed in 1907 by professionals in the field of cancer research, treatment and academics. The objective of AACR is accelerate progress in the prevention, cure and treatment of cancer through research, education, communication and advocacy. The AACR Foundation is the fundraising component of AACR. Each year the AACR provides research grants to leading scientists and universities in the filed of cancer research. AACR publishes seven journals that run that gamut of cancer related research. These journals are; Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics, Molecular Cancer Research, Cancer Epidemiology Biomarkers and Prevention, Cancer Prevention Research and CR Magazine. Each month AACR publishes up to six free abstracts of research funded by or supported by AACR. Additionally, AACR has a comprehensive on-line Cancer dictionary which includes the latest on the numerous varieties of cancers and treatments modalities. AACR is exceptionally open to the public and the media for inquiries about their work.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 ...
Apr 17, 2023
0
75
During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income countries faced a higher risk of all-cause mortality than those in high-income countries, according to data presented ...
Apr 11, 2022
0
54
Visceral fat, or fat stored deep in the abdominal cavity, is directly linked to an increased risk for colon cancer, according to data from a mouse study published in Cancer Prevention Research, a journal of the American Association ...
Mar 6, 2013
0
0
Poly (ADP-Ribose) polymerase (PARP) inhibitors, shown to have clinical activity when used alone in women with familial breast and ovarian cancers linked to BRCA mutations, may be a novel treatment strategy in women with HER2-positive ...
Sep 17, 2012
0
0
Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.
Dec 29, 2011
0
0
Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal ...
Apr 15, 2011
0
0
TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous cell cancer (HNSCC), according ...
Apr 9, 2024
0
14
A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins CA125 and HE4 could differentiate patients with ovarian cancer from healthy controls or patients with benign ...
Apr 9, 2024
0
0
AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent and newly diagnosed glioblastoma (GBM) patients when given in combination with standard-of-care radiotherapy ...
Apr 9, 2024
0
1
Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated with higher risk of metastasis and/or recurrence of the disease, according to a study presented at the American ...
Apr 9, 2024
0
0
